×
App Icon
The Standard e-Paper
Read Offline Anywhere
★★★★ - on Play Store
Download Now

US vaccine giant Moderna 'suspends' plans to build Sh65b plant in Kenya

Vocalize Pre-Player Loader

Audio By Vocalize

Moderna Inc inked a deal in 2022 with the Kenyan government to invest billions of shillings in a facility that would produce up to 500 million vaccine shots a year. [iStsockphoto]

US biotechnology giant Moderna says it has suspended plans to build a vaccine Sh65 billlion plant in Kenya.

The American firm inked a deal in 2022 with the Kenyan government to invest billions of shillings in a facility that would produce up to 500 million vaccine shots a year.

Premium Article

Get Full Access for Ksh299/Week.

Fact-first reporting that puts you at the heart of the newsroom. Subscribe for full access.
Continue Reading  →
What you get
  • Unlimited access to all premium content
  • Ad-free browsing experience
  • Mobile-optimised reading
  • Weekly newsletters & digests
Pay via
M - PESA
VISA
Airtel Money
Secure Payments Kenya's most trusted newsroom since 1902
Business
How the global oil crisis has increased Kenya's fuel import costs
Financial Standard
New bid to end delay of county salaries, statutory remittances row
Business
Tea farmers queue at banks for bonuses as low payouts spark tax protests
Financial Standard
Firewood, charcoal dominate kitchens despite big investments in clean cooking